一、【Exclusive patent】The company has independent intellectual property rights of the left ornidazole synthesis process, compared with the current left ornidazole products, the process does not involve the use of aluminum trichloride, environmental pollution is small, product safety is high.

二、【Drug advantages】Leornidazole is a single optical enantiomer of Ornidazole and belongs to nitroimidazole antimicrobials.Compared with common ornidazole racemes, the application of L-ornidazole can significantly reduce the adverse reactions associated with the use of Ornidazole drugs.The data showed that the incidence of adverse reactions was 21.58% when the therapeutic dose of ornidazole was used, while the rate of adverse reactions was reduced to 1.47% when the same level of levoornidazole was given.At present, drugs with leornidazole as the active ingredient are emerging, constantly updating and replacing the original Ornidazole products, providing people with better drug choices.

三、【Use】Used as anti-anaerobic bacteria and antigenic insect drugs.